NCT02707445View on ClinicalTrials.gov

Genotyping Influences Outcome of Coronary Artery Stenting

NACompletedINTERVENTIONAL

Enrollment

5,000

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Myocardial IschemiaCLOPIDOGREL, POOR METABOLISM of (Disorder)

Interventions

DRUG

Clopidogrel

Administration of conventional dual anti-platelet treatment (aspirin 100mg and clopidogrel 75mg daily) for minimum 3 months after percutaneous coronary intervention

All Listed Sponsors

lead

Korea University Anam Hospital

OTHER

NCT02707445 - Genotyping Influences Outcome of Coronary Artery Stenting | Biotech Hunter | Biotech Hunter